Marketstrat Receives USPTO Registration for Markintel® Service Mark
Registration reinforces Marketstrat’s commitment to building a structured market intelligence system for MedTech, medical imaging, imaging AI, and adjacent healthcare technology markets. SACRAMENTO, Calif. — Apr. 28, 2026 — Marketstrat Inc. announced today that the United States Patent and Trademark Office has registered Markintel® as a service mark of Marketstrat Inc. The registration marks an […]
Sectra Completes Oxipit Acquisition (2026-04-15)
Sectra / Oxipit — Market Signals | Marketstrat Marketstrat|Market Signals Deal Intelligence · MedTech Event-Driven Analysis No. 02 · April 2026 M&A · Radiology AI · EU → EU Sectra pulls autonomous AI inside the enterprise imaging stack. Completion of the Oxipit acquisition consolidates the independent autonomous chest X-ray AI market into two platforms in […]
Owned Workflow Gets Paid: Imaging AI Reimbursement, Spectral CT, PACS-AI Consolidation, and Image-Guided MIS
Reimbursable chest-CT AI, modality-native software, and platform ownership shift value from model novelty to monetized workflow control. Marketstrat® Pulse Insights | Week ending April 17, 2026Coverage: Medical Imaging AI | Enterprise Imaging IT | Imaging Reimbursement | AI-Enabled MedTech | Image-Guided MIS 🎧 Listen to this week’s Marketstrat Pulse Insight: If the April 10 week […]
Neuropacs De Novo: First FDA-Authorized AI Pathway for Chronic Neurodegenerative Disease Differentiation
Event Date: April 3, 2026 (FDA decision) | April 7, 2026 (public announcement) Marketstrat® · Markintel Market Signals Neuropacs De Novo: First FDA-Authorized AI Pathway for Chronic Neurodegenerative Disease Differentiation Published: April 16, 2026 Sector: MedTech & Digital Health Focus: Neurological Imaging AI FDA grants De Novo classification to neuropacs™ (April 3, 2026) Creates a […]
Routability Becomes the Moat – April 10, 2026
Prior authorization reform, workflow control, and provider-scale validation re-rank imaging AI KEY TAKEAWAYS COMMERCIALIZATION SURFACE MAP The Commercialization Surface Map explains where this week’s value sat. It plots the major signals by deployment-surface control and clinical or regulatory novelty, with bubble size reflecting strategic impact. The pattern is the story: the strongest signals clustered where […]
Validated Workflow Starts to Beat the Algorithm Pitch – April 3, 2026
Dual ACC physiology trials, lower-operator maternal ultrasound, and distribution-rail concentration push imaging software closer to budgetable infrastructure ONE BIG THING The most important shift this week was not another point-model launch. It was convergence: two large, randomized ACC readouts materially de-risked software-first coronary physiology, Butterfly cleared a lower-skill obstetric ultrasound workflow at the point of […]
The Highest-Value AI Frontier Is Shifting from Interpretation to Acquisition
Innovation Hook · Butterfly Network (NYSE: BFLY) The Highest-Value AI Frontier Is Shifting from Interpretation to Acquisition FDA clearance of first blind-sweep gestational age tool · March 30, 2026 Most radiology AI analyzes images after a skilled operator captures them. Butterfly’s GA Tool automates the scan itself — eliminating the operator skill requirement entirely. That […]
Commercialization Plumbing Beats Novelty – March 27, 2026
CMS coding, provider-IT rails, and MRI resilience reset the imaging AI stack ONE BIG THING This week’s most important shift was that imaging AI moved another step away from “interesting software” and toward operational infrastructure. CMS published HCPCS G0680 (effective April 1) for software analysis of coronary artery calcium and aortic valve calcification from chest […]
Marketstrat Releases ‘Global Ultrasound Horizon: Market Structure, Forecasts, and AI Monetization Architecture’ Report
New Markintel™ Horizon report maps the global ultrasound ecosystem from $12.5B (2024A) to $21.5B (2035E) and explains how value shifts to workflow, AI, cloud, and governance. SACRAMENTO, CA, UNITED STATES, April 7, 2026 /EINPresswire.com/ — Marketstrat today announced the release of its latest Markintel™ Horizon report, “Global Ultrasound Horizon: Market Structure, Forecasts, and AI Monetization […]
Platform Control Becomes Owned Infrastructure; Screening AI Shows Real Labor Proof – March 20, 2026
GE’s Intelerad close turns enterprise imaging strategy into balance-sheet reality, while new screening evidence and cyber/helium disruptions sharpen what buyers will actually fund ONE BIG THING Enterprise imaging crossed from conference narrative into owned infrastructure this week: GE’s Intelerad close made platform control tangible, new breast-screening AI data made labor relief more credible, and cyber/helium […]
